London, United Kingdom

Ruth Bridget Ferns

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruth Bridget Ferns. Retrieved from https://idiyas.com/inventor/ruth-bridget-ferns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ruth Bridget Ferns: Innovator in Hepatitis B Research

Introduction

Ruth Bridget Ferns is a distinguished inventor based in London, GB. She has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies for the detection and treatment of Hepatitis B.

Latest Patents

Ruth holds a patent for "Hepatitis B monoclonal antibodies." This innovative monoclonal antibody is capable of binding specifically to wild type HBsAg and to at least two mutant forms of HBsAg. It may be utilized in an improved immunoassay for the detection of both escape mutants and wild type HBsAg. Additionally, it has potential applications for passive immunization against HBV.

Career Highlights

Throughout her career, Ruth has demonstrated a commitment to advancing medical science. Her work has been pivotal in enhancing diagnostic methods and therapeutic options for Hepatitis B, a virus that poses significant health risks worldwide.

Collaborations

Ruth has collaborated with notable colleagues, including Richard Seton Tedder and Samreen Ijaz. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.

Conclusion

Ruth Bridget Ferns is a remarkable inventor whose work in Hepatitis B research exemplifies the impact of innovation in medicine. Her contributions continue to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…